Occurrence of blaNDM-1, blaNDM-5, blaNDM-7, and blaKPC-2 genes in clinical isolates of enterobacterales with high genetic variability, from colonization and infection in patients with or without COVID-19, from a hospital in Brazil.

AIMS: This study aimed to investigate the presence of beta-lactams resistance genes and the clonal relationship of clinical isolates of Enterobacterales obtained from patients with and without COVID-19, in a hospital in northeastern Brazil. METHODS AND RESULTS: The study analyzed 45 carbapenem-resistant clinical isolates using enterobacterial repetitive intergenic consensus (ERIC-PCR), PCR, and amplicon sequencing to detect resistance genes (blaKPC, blaGES, blaNDM, blaVIM, and blaIMP). The main species were Klebsiella pneumoniae, Serratia marcescens, and Proteus mirabilis. Detected genes included blaNDM (46.66%), blaKPC (35.55%), and both (17.79%). ERIC-PCR showed multiclonal dissemination and high genetic variability. The main resistance gene was blaNDM, including blaNDM-5 and blaNDM-7. CONCLUSIONS: The presence of Enterobacterales carrying blaKPC and blaNDM in this study, particularly K. pneumoniae, in infections and colonizations of patients with COVID-19 and non-COVID-19, highlights genetic variability and resistance to carbapenems observed in multiple species of this order.

Genetic profile and characterization of antimicrobial resistance in Acinetobacter baumannii post-COVID-19 pandemic: a study in a tertiary hospital in Recife, Brazil.

AIMS: To investigate the genetic profile and characterize antimicrobial resistance, including the main ß-lactam antibiotic resistance genes, in Acinetobacterbaumannii isolates from a tertiary hospital in Recife-PE, Brazil, in the post-COVID-19 pandemic period. METHODS AND RESULTS: Acinetobacter baumannii isolates were collected between 2023 and 2024 from diverse clinical samples. Antimicrobial resistance testing followed standardized protocols, with ß-lactamase-encoding genes detected via PCR and sequencing. Investigation into ISAba1 upstream of blaOXA-carbapenemase and blaADC genes was also conducted. Genetic diversity was assessed through ERIC-PCR. Among the 78 A. baumannii, widespread resistance to multiple antimicrobials was evident. Various acquired ß-lactamase-encoding genes (blaOXA-23,-24,-58,-143, blaVIM, and blaNDM) were detected. Furthermore, this is the first report of blaVIM-2 in A. baumannii isolates harboring either the blaOXA-23-like or the blaOXA-143 gene in Brazil. Molecular typing revealed a high genetic heterogeneity among the isolates, and multi-clonal dissemination. CONCLUSION: The accumulation of genetic resistance determinants underscores the necessity for stringent infection control measures and robust antimicrobial stewardship programs to curb multidrug-resistant strains.

Virulent Klebsiella pneumoniae ST11 clone carrying blaKPC and blaNDM from patients with and without COVID-19 in Brazil.

AIMS: Investigated and compared the occurrence of virulence genes fimH, mrkD, irp2, entB, cps, rmpA, and wabG, resistance genes blaKPC and blaNDM, and the genetic variability and clonal relationship of 29 Klebsiella pneumoniae clinical isolates of patients with and without COVID-19, from a hospital in Brazil. METHODS AND RESULTS: All isolates were resistant to beta-lactams. The genes were investigated by PCR, and for molecular typing, enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) and MLST were used. The detection of blaNDM was greater (n = 23) when compared to that of blaKPC (n = 14). The virulence genes that most occurred were fimH, entB, cps, and wabG, which are responsible for adhesins, siderophore enterobactin, capsule, and lipopolysaccharides, respectively. Among the isolates, 21 distinct genetic profiles were found by ERIC-PCR, with multiclonal dissemination. Four isolates belonged to the ST11 clone. CONCLUSIONS: The occurrence of the ST11 is worrying as it is a high-risk clone involved in the dissemination of virulent strains throughout the world.

Identification and characterization of bacterial biofilm production in clinical isolates of Staphylococcus spp. against antimicrobials / Identificação e caracterização da produção de biofilme bacteriano em isolados clínicos de Staphylococcus spp. frente aos antimicrobianos / Identificación y caracterización de la producción de biopelículas bacterianas en aislamientos clínicos de Staphylococcus spp. contra los antimicrobianos

Justification and Objectives: Circulating blood is sterile and the presence of microorganisms can be of clinical interest, especially in the hospital environment, being able to cause infectious processes and substantially increase morbidity and mortality. The objective of this work was to characterize the isolates of the genus Staphylococcus spp. from bloodstream infections as to the production of bacterial biofilm and resistance to the main antimicrobials used in clinical practice. Methods: Blood cultures were collected with an indication of positivity for bacterial growth from multiple sectors of the study hospital, which were subsequently processed to identify the bacterial genus through the use of phenotypic tests for Gram positive bacteria. The verification of the resistance profile was performed following the Kirby-Bauer disk diffusion. The identification of the production and quantification of the bacterial biofilm occurred following the protocol described by O'toole (2010). Results: The most frequent clinical isolate was Coagulase negative Staphylococci 38 (54.29%), followed by Staphylococcus aureus 32 (45.71%). Resistance to erythromycin, norfloxacin, levofloxacin and azithromycin was observed in most isolates (70%). Regarding methicillin, more MRSA (59.38%) than MR-CONS (47.37%) were isolated. The ICU was the place where the formation of the biofilm showed indicative data of greater adherence, which was associated with MRSA strains. Conclusion: The bacterial isolates associated with bloodstream infections showed high resistance to antimicrobials. The presence of MRSA and MR-CONS with strong and/or moderate biofilm production capacity represents a greater risk to the health of patients affected by infections caused by these agents.(AU)

Justificativa e Objetivos: O sangue circulante é estéril e a presença de microrganismos pode ter interesse clínico, especialmente no ambiente hospitalar, sendo capaz de causar processos infecciosos e aumentar substancialmente a morbimortalidade. O objetivo deste trabalho foi caracterizar os isolados do gênero Staphylococcus spp. oriundos de infecções de corrente sanguínea quanto à produção de biofilme bacteriano e resistência aos principais antimicrobianos utilizados na prática clínica. Métodos: Foram coletadas hemoculturas com indicação de positividade para o crescimento bacteriano de múltiplos setores do hospital de estudo, as quais posteriormente foram processadas para identificação do gênero bacteriano através da utilização de testes fenotípicos para bactérias Gram positivas. A verificação do perfil de resistência foi realizada seguindo a metodologia de disco difusão de Kirby-Bauer. A identificação da produção e quantificação do biofilme bacteriano ocorreu seguindo o protocolo descrito por O'toole (2010). Resultados: O isolado clínico mais frequente foi o Staphylococcus coagulase negativo 38 (54,29%), seguido pelo Staphylococcus aureus 32 (45,71%). A resistência à eritromicina, norfloxacina, levofloxacina e azitromicina foi observada na maioria dos isolados (70%). Em relação à meticilina, foram isolados mais Staphylococcus aureus resistente à meticilina (MRSA) (59,38%) que Staphylococcus coagulase negativa resistente à meticilina (MR-CONS) (47,37%). A UTI foi o local onde a formação do biofilme apresentou dados indicativos de maior aderência, sendo essa associada às cepas MRSA. Conclusão: Os isolados bacterianos associados às infecções da corrente sanguínea apresentaram elevada resistência aos antimicrobianos. A presença de MRSA e MR-CONS com forte e/ou moderada capacidade de produção de biofilme representa maior risco à saúde dos pacientes acometidos por infecções causadas por estes agentes.(AU)

Justificación y objetivos: la sangre circulante es estéril y la presencia de microorganismos puede ser de interés clínico, especialmente en el entorno hospitalario, ya que puede causar procesos infecciosos y aumentar sustancialmente la morbilidad y la mortalidad. El objetivo de este trabajo fue caracterizar los aislamientos del género Staphylococcus spp. de infecciones del torrente sanguíneo en cuanto a la producción de biopelículas bacterianas y la resistencia a los principales antimicrobianos utilizados en la práctica clínica. Métodos: Se recogieron hemocultivos con una indicación de positividad para el crecimiento bacteriano de múltiples sectores del hospital de estudio, que posteriormente se procesaron para identificar el género bacteriano mediante el uso de pruebas fenotípicas para bacterias Gram positivas. La verificación del perfil de resistencia se realizó siguiendo la metodología de difusión de disco de Kirby-Bauer. La identificación de la producción y cuantificación de la biopelícula bacteriana se produjo siguiendo el protocolo descrito por O'toole (2010). Resultados: El aislado clínico más frecuente fue Staphylococcus coagulasa negativo 38 (54.29%), seguido de Staphylococcus aureus 32 (45.71%). Se observó resistencia a la eritromicina, norfloxacina, levofloxacina y azitromicina en la mayoría de los aislamientos (70%). Con respecto a la meticilina, se aislaron más MRSA (59,38%) que MR-CONS (47,37%). La UCI fue el lugar donde la formación de la biopelícula mostró datos indicativos de una mayor adherencia, que se asoció con las cepas de MRSA. Conclusión: los aislamientos bacterianos asociados con infecciones del torrente sanguíneo mostraron una alta resistencia a los antimicrobianos. La presencia de MRSA y MR-CONS con una capacidad de producción de biopelículas fuerte y / o moderada representa un mayor riesgo para la salud de los pacientes afectados por infecciones causadas por estos agentes.(AU)